Adjuvant vinorelbine plus cisplatin versus vinorelbine plus cisplatin plus Endostar [endostatin] in patients with completely resected stage IB-IIIA non-small cell lung cancer (phase III study, randomized, open, multi-center).
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Jun 2012 Preliminary results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.
- 08 Jun 2010 Interim results from 545 patients presented at 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).